Immediate Impact
30 standout
Citing Papers
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Works of Angela Mayo being referenced
Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma
2015
A phase I/II trial of cyclophosphamide, carfilzomib, thalidomide, and dexamethasone (CYCLONE) in patients with newly diagnosed multiple myeloma.
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Angela Mayo | 157 | 130 | 78 | 14 | 227 | |
| Mustafa Genco Erdem | 21 | 55 | 37 | 29 | 264 | |
| Koji Sano | 64 | 17 | 21 | 21 | 249 | |
| C. Andreis | 20 | 51 | 18 | 23 | 278 | |
| Xi-xi Li | 124 | 204 | 31 | 13 | 295 | |
| Victor S. Lin | 65 | 38 | 40 | 14 | 268 | |
| Shaadi Mehr | 22 | 49 | 16 | 13 | 104 | |
| Isabelle Bartram | 100 | 86 | 45 | 13 | 258 | |
| Zhilian Hu | 44 | 101 | 5 | 8 | 212 | |
| Juha Mehtonen | 45 | 139 | 31 | 19 | 240 | |
| Yong Dong | 44 | 76 | 15 | 32 | 207 |
All Works
Loading papers...